| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3992333 | Journal of Thoracic Oncology | 2008 | 7 Pages |
Abstract
WSE is associated with better response to Erlotinib and improved progression-free survival in patients with NSCLC. Additional studies in epidermal growth factor receptor signaling pathway in WSE-associated NSCLC are warranted.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Oscar MD, Luis MD, Sergio MD, Enrique MD, Patricia MD, Miguel Angel MD, Diana SW, Eduardo MD, Cesar MD, Johny MD, Claudia Haydee MD, PhD, Norma BS, Rafael MD, Jaime MD,